TABLE 1.
Fraction | Treatment | Genotype | Bmax ± S.E.M. | Kd ± S.E.M. |
---|---|---|---|---|
pmol/mg protein | nM | |||
Synaptosomal | Saline | Taar1 WT | 1.4 ± 0.2 | 2.3 ± 0.5 |
Taar1 KO | 1.5 ± 0.2 | 2.4 ± 0.4 | ||
MA | Taar1 WT | 1.3 ± 0.2 | 2.3 ± 0.4 | |
Taar1 KO | 1.3 ± 0.2 | 2.3 ± 0.2 | ||
Membrane-associated | Saline | Taar1 WT | 1.9 ± 0.3 | 2.3 ± 0.5 |
Taar1 KO | 2.0 ± 0.5 | 2.3 ± 0.7 | ||
MA | Taar1 WT | 1.9 ± 0.3 | 2.3 ± 0.6 | |
Taar1 KO | 1.5 ± 0.3 | 2.4 ± 0.5 | ||
Vesicular | Saline | Taar1 WT | 1.0 ± 0.2 | 2.2 ± 0.3 |
Taar1 KO | 1.2 ± 0.1 | 3.4 ± 1.0 | ||
MA | Taar1 WT | 0.8 ± 0.2* | 1.2 ± 0.1* | |
Taar1 KO | 0.6 ± 0.1* | 1.1 ± 0.1* |
P < 0.05 compared with saline treatment (main effect).